Benzinga | Jul 29, 2020 07:50AM EDT

Gene Technologies Spikes Higher, Above $5 Level, After Company Reports Quarterly Activities Report

https://www.sec.gov/Archives/edgar/data/1166272/000149315220014129/ex99-1.htm



Highlights



? Successful capital raisings of US$16.34m before costs ? AUD$20.23m cash balance at 28 July 2020 ? Genetic Technologies provides update on COVID-19 disease severity test ? Consumer Initiated Sales for Existing Pipeline ? US Patent Office Grants Key Risk Test Patent ? COVID-19 Severity test Provisional Patent Application Filed in Australia ? Capability to transition to high throughput Covid-19 testing ? Nata and CLIA Lab for USA and Australian Markets